Skip to content

A prospective cohort study of Jintiange capsules on pain, activities of daily living and quality of life in patients with knee osteoarthritis

A prospective cohort study of Jintiange capsules on pain, activities of daily living and quality of life in patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065257
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with knee osteoarthritis

Interventions

Lianlian Tiange capsule group: None
conventional therapy group:None

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients with definite diagnosis of knee joint; 2.Patients aged 40-70; 3.In the past week,VAS pain scores ranged from 2.0 to 7.0; 4.Patients with knee X-ray Kellgren-Lawrence grading score of 1-3; 5.It is suitable for patients taking Jintiange capsule after dialectical by traditional Chinese medicine doctors.

Exclusion criteria

Exclusion criteria: 1.Those with cognitive impairment or other dysfunction cannot complete the assessment; 2.Patients with serious life-threatening primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, as well as psychosis; 3.Patients taking glucocorticoids and other drugs that may affect the efficacy at the same time; 4.Patients who are unwilling to participate in this study; 5.Patients who also affect the knee joint, such as bone tuberculosis, bone tumor, acute trauma of the knee joint, infection, psoriasis, syphilitic neuropathy, etc; 6.Patients with skin damage of knee joint;

Design outcomes

Primary

MeasureTime frame
pain;Activities of daily living;

Secondary

MeasureTime frame
PROMIS pain interference;Quality of life;Functional testing;

Countries

China

Contacts

Public ContactJianxiong Wang

The Affiliated Hospital of Southwest Medical University

380030472@qq.com+86 18283012266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026